High-Dose Statins IDEAL For Use In High-Risk Patients, Study Suggests
Executive Summary
Results of the IDEAL study support the aggressive use of high-dose statins as standard therapy for patients at high risk of repeat cardiovascular events, Scott Grundy (University of Texas Southwestern Medical Center) told the American Heart Association annual meeting Nov. 15 in Dallas
You may also be interested in...
Singulex’ Cardiac Troponin Test Predicts Cardiac Risk In Stable Patients
Results of from a new analysis of plasma samples from an old statin trial suggest that Singulex’ high-sensitivity cardiac troponin test can track the cardiovascular risk in stable patients with ischemic heart disease.
Lipitor Adds Claims For High-Dose Use From TNT, IDEAL – But Label Is Mixed
Lipitor (atorvastatin) has gained approval for five new indications based on the Treating to New Targets and Incremental Decrease in Endpoints Through Aggressive Lipid Lowering studies, but the updated labeling includes mixed statements about the benefits of treatment with higher doses of atorvastatin
Lipitor Adds Claims For High-Dose Use From TNT, IDEAL – But Label Is Mixed
Lipitor (atorvastatin) has gained approval for five new indications based on the Treating to New Targets and Incremental Decrease in Endpoints Through Aggressive Lipid Lowering studies, but the updated labeling includes mixed statements about the benefits of treatment with higher doses of atorvastatin